Literature DB >> 1657792

The molecular biology of eosinophil granule proteins.

K J Hamann1, R L Barker, R M Ten, G J Gleich.   

Abstract

Here, we briefly review the molecular biology of the human eosinophil granule proteins, major basic protein (MBP), eosinophil peroxidase (EPO), eosinophil cationic protein (ECP) and eosinophil-derived neurotoxin (EDN). The nucleotide sequence of MBP cDNA indicates that MBP is translated as a 25.2-kilodalton preproprotein; the mpb gene consists of 6 exons and 5 introns spanning 3.3 kilobases (kb). The approximately 2.1-kb nucleotide sequence of EPO cDNA corresponds to a prosequence, light chain and heavy chain in that order; similarities to other peroxidases suggest the existence of a multigene family. EDN and ECP cDNAs and genes are remarkably similar throughout, suggesting a relatively recent divergence. Promoter regions of the 4 genes show interesting differences and similarities which may be related to differential gene regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657792     DOI: 10.1159/000235362

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  17 in total

Review 1.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

2.  The murine eosinophil major basic protein gene (Prg2) maps to chromosome 2.

Authors:  K L Denzler; W J Levin; P A Quiram; N A Lee; J J Lee
Journal:  Mamm Genome       Date:  1997-05       Impact factor: 2.957

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

Review 4.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

5.  Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis.

Authors:  Violetta Borelli; Francesca Vita; Sandeep Shankar; Maria Rosa Soranzo; Elena Banfi; Giuditta Scialino; Cristiana Brochetta; Giuliano Zabucchi
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

6.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 7.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

8.  Human eosinophil major basic protein, a mediator of allergic inflammation, is expressed by alternative splicing from two promoters.

Authors:  M S Li; L Sun; T Satoh; L M Fisher; C J Spry
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

9.  ICON: Eosinophil Disorders.

Authors:  Peter Valent; Amy D Klion; Lanny J Rosenwasser; Michel Arock; Bruce S Bochner; Joseph H Butterfield; Jason Gotlib; Torsten Haferlach; Andrzej Hellmann; Hans-Peter Horny; Kristin M Leiferman; Georgia Metzgeroth; Kenji Matsumoto; Andreas Reiter; Florence Roufosse; Marc E Rothenberg; Hans-Uwe Simon; Karl Sotlar; Peter Vandenberghe; Peter F Weller; Gerald J Gleich
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

Review 10.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.